Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
about
Antiplatelet and anticoagulant agents for preventing recurrence of peripheral vascular thrombosis in patients with Antiphospholipid syndromeAnnexin A2 is involved in antiphospholipid antibody-mediated pathogenic effects in vitro and in vivo.Rituximab therapy for recurrent thromboembolic disease in antiphospholipid syndrome.Thrombophilia and Pregnancy
P2860
Prothrombotic mechanisms based on the impairment of fibrinolysis in the antiphospholipid syndrome.
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on October 2008
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Prothrombotic mechanisms based ...... the antiphospholipid syndrome.
@en
Prothrombotic mechanisms based ...... the antiphospholipid syndrome.
@nl
type
label
Prothrombotic mechanisms based ...... the antiphospholipid syndrome.
@en
Prothrombotic mechanisms based ...... the antiphospholipid syndrome.
@nl
prefLabel
Prothrombotic mechanisms based ...... the antiphospholipid syndrome.
@en
Prothrombotic mechanisms based ...... the antiphospholipid syndrome.
@nl
P2860
P356
P1433
P1476
Prothrombotic mechanisms based ...... the antiphospholipid syndrome.
@en
P2093
M Martinuzzo
R Forastiero
P2860
P304
P356
10.1177/0961203308091633
P577
2008-10-01T00:00:00Z